The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma

NCT05841550 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Smoldering Multiple Myeloma

Interventions

BIOLOGICAL: TG01

Sponsor

Oslo University Hospital

Collaborators

[object Object]